Related Experiment Videos
Pharmacogenomics in drug development: societal and technical aspects
1Department of Neuropharmacology, Harold L Dorris Neurological Research Center, The Scripps Research Institute, La Jolla, CA 92037, USA. tbartfai@scripps.edu
The Pharmacogenomics Journal
|May 5, 2004
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Galanin, galanin receptors, and drug targets.
Experientia supplementum (2012)·2011
IL-1/IL-1ra balance in the brain revisited - evidence from transgenic mouse models.
Brain, behavior, and immunity·2009
Galanin, galanin receptors and drug targets.
Cellular and molecular life sciences : CMLS·2008
Galanin type 1 receptor knockout mice show altered responses to high-fat diet and glucose challenge.
Physiology & behavior·2007
Large-scale analysis demonstrates the influence of CYP2C19 genotype on specific SSRI side effects.
The pharmacogenomics journal·2026
Effects of CYP3A4, CYP3A5, and ABCB1 genetic variants on tacrolimus metabolism during the early period after kidney transplantation.
The pharmacogenomics journal·2026
Understanding public perspectives on direct-to-consumer pharmacogenomic testing in the UK: a qualitative study.
The pharmacogenomics journal·2026
Toxicity related to immunotherapy in urothelial cancer: Tumour genetic risk variants.
The pharmacogenomics journal·2026
Beyond the 'Pregnancy Black Box': a global roadmap for artificial intelligence-driven pharmacogenomics in maternal-neonatal health.
The pharmacogenomics journal·2026
Effectiveness and Safety of Spesolimab in Adolescents and Adults with Generalized Pustular Psoriasis.
Pragmatic and observational research·2026
Preclinical Evaluation of Anti-Acne Topical Creams Containing Psorospermum Febrifugum Stem Bark Extract: Lipase Inhibition, Sebum Regulation, and Dermal Safety.
Clinical, cosmetic and investigational dermatology·2026
Impact of Hydrogel Spacer on Radiation Proctitis After Prostate Cancer Radiation Therapy: A Large-Scale Claims Database Analysis.
Advances in radiation oncology·2026
Discovery of a Potent and Selective KRAS G12D Degrader based on PROTAC Degradation.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026